Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

CVRX stock hub

CVRx, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

CVRXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
180.5M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
CVRX
In the news

Latest news · CVRX

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-96.6
P25 -105.6P50 -46.5P75 -3.1
ROIC-30.3
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All CVRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
204
Groups with data
11
Currency
USD
Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001235912
Company name
CVRx, Inc.
Country
United States
Country code
US
Cusip
126638105
Employees
223
Employees Change
17%
Employees Change Percent
8.25
Enterprise value
$155.3M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Medical Devices
IPO Date
2021-06-30
Isin
US1266381052
Last refreshed
2026-05-10
Market cap
$180.5M
Market cap category
Micro-Cap
Price
$6.83
Price currency
USD
Rev Per Employee
254,040.36x
Sector
Healthcare
Sic
3841
Symbol
CVRX
Website
https://www.cvrx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-29.53%
EV Sales Forward
2.34x
EV/Sales
2.74x
FCF yield
-22.57%
P/B ratio
4.57x
P/S ratio
3.19x
PS Forward
2.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-90.49%
EBITDA Margin
-89.16%
Gross margin
85.33%
Gross Profit
$48.3M
Gross Profit Growth
12.53%
Gross Profit Growth Q
8.25%
Gross Profit Growth3 Y
40.39%
Gross Profit Growth5 Y
59.98%
Net Income
$-53.3M
Net Income Growth Years
1%
Pretax Margin
-94.13%
Profit Margin
-94.1%
Profit Per Employee
$-239,040
ROA
-26.9
Roa5y
-22.67
ROCE
-56.04
ROE
-96.59
Roe5y
-60.46
ROIC
-30.32

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr1y
-8.7%
Cagr3y
-18.48%
EPS Growth Years
1
Revenue Growth
10.45x
Revenue Growth Q
4.45x
Revenue Growth Quarters
20x
Revenue Growth Years
5x
Revenue Growth3 Y
36.11x
Revenue Growth5 Y
56.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
$0.48
Assets
$104.8M
Cash
$75.7M
Current Assets
$101.6M
Current Liabilities
$13.3M
Debt
$50.5M
Debt Equity
$1.28
Equity
$39.3M
Interest Coverage
-8.8
Liabilities
$65.5M
Long Term Assets
$3.1M
Long Term Liabilities
$52.2M
Net Cash
$25.2M
Net Cash By Market Cap
$13.96
Net Cash Growth
-54.59%
Net Debt Equity
$-0.64
Tangible Book Value
$39.3M
Tangible Book Value Per Share
$1.49
WACC
9.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
7.63
Inventory Turnover
0.68
Net Working Capital
$13M
Quick ratio
6.49
Working Capital
$88.3M
Working Capital Turnover
$0.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-15.44%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
-8.69%
200-day SMA
8.01
3Y total return
-45.84%
50-day SMA
8.01
50-day SMA vs 200-day SMA
50under200
All Time High
33.14
All Time High Change
-79.39%
All Time High Date
2023-12-29
All Time Low
4.3
All Time Low Change
58.87%
All Time Low Date
2025-05-12
ATR
0.6
Beta
0.87
Beta1y
1.23
Beta2y
0.86
Ch YTD
-3.8
High
7.23
High52
11.3
High52 Date
2025-11-03
High52ch
-39.56%
Low
6.69
Low52
4.3
Low52 Date
2025-05-12
Low52ch
58.87%
Ma50ch
-14.74%
Price vs 200-day SMA
-14.74%
RSI
40.62
RSI Monthly
42.73
RSI Weekly
45.61
Sharpe ratio
0.3x
Sortino ratio
0.48
Total Return
-15.44%
Tr YTD
-3.8
Tr1m
-18.4%
Tr1w
-14.3%
Tr3m
4.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

9
MetricValue
Analyst Count
4
Analyst Ratings
Buy
Earnings EPS Estimate
$-0.51
Earnings Revenue Estimate
14,548,000x
Earnings Revenue Estimate Growth
18.28x
Operating Income
$-51.3M
Operating margin
-90.49
Price target
$10.5
Price Target Change
$53.73

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
18,284,211%
Float Percent
69.18%
Shares Insiders
0.7%
Shares Institutions
42.6%
Shares Out
26,430,915
Shares Qo Q
-0.32%
Shares Yo Y
15.44%
Short Float
9.13%
Short Ratio
6.87
Short Shares
6.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

62
MetricValue
Adjusted FCF
$-51.8M
Average Volume
258,832.4x
Bv Per Share
1.49
CAPEX
$-580,000
Ch1m
-18.4
Ch1w
-14.3
Ch1y
-8.69
Ch3m
4.28
Ch3y
-45.84
Ch6m
-29.66
Change
-6.69%
Change From Open
-5.4
Close
7.32
Days Gap
-1.37
Depreciation Amortization
756,000
Dollar Volume
1,325,955.7
Earnings Date
2026-05-11
Earnings Time
amc
EBIT
$-51.3M
EBITDA
$-50.5M
EPS
$-2.04
F Score
3
FCF
$-40.8M
FCF EV Yield
-26.24x
FCF Per Share
$-1.54
Financing CF
10,520,000
Fiscal Year End
December
Founded
2,000
Income Tax
$-18,000
Investing CF
-580,000
Ipr
-62.06
Iprfo
-73.98
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-02-12
Last Report Date
2025-12-31
Last Split Type
Never
Last10k Filing Date
2026-02-13
Ma150
8.15
Ma150ch
-16.2%
Ma20
7.5
Ma20ch
-8.87%
Net CF
-30,225,000
Next Earnings Date
2026-05-11
Open
7.22
Optionable
Yes
Position In Range
25.93
Post Close
6.83
Postmarket Change Percent
-1.17
Postmarket Price
$6.75
Ppne
3,121,000
Price Date
2026-05-08
Ptbv Ratio
4.59
Relative Volume
0.75x
Revenue
56,651,000x
SBC By Revenue
19.51x
Share Based Comp
11,052,000
Tax By Revenue
-0.03x
Tr6m
-29.66%
Us State
Minnesota
Volume
194,137
Z Score
-5.74
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does CVRX pay a dividend?

Capital-return profile for this ticker.

Performance

CVRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-8.7%
S&P 500 1Y: n/a
3Y total return
-45.8%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns CVRX?

Insider, institutional, and short-interest positioning.

Institutional ownership
+42.6%
Float: +69.2% of shares outstanding
Insider ownership
+0.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+9.1%
6.9 days to cover
Y/Y dilution
+15.4%
Negative means the company is buying back shares.
Technical

CVRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
40.6
Neutral momentum band
Price vs 200-day MA
-14.7%
50/200-day relationship not available
Beta (5Y)
0.87
Moves roughly with the market
Sharpe ratio
0.30
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About CVRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CVRX stock rating?

CVRx, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CVRX analysis?

The full report lives at /stocks/CVRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CVRX?

The latest report frames CVRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CVRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.